| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.07 | 0.6 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.6 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |